Calcified Tissue International

, Volume 73, Issue 2, pp 133–139 | Cite as

Alendronate Treatment in Men With Primary Osteoporosis: A Three-Year Longitudinal Study

  • S. Gonnelli
  • C. Cepollaro
  • A. Montagnani
  • D. Bruni
  • C. Caffarelli
  • M. Breschi
  • L. Gennari
  • C. Gennari
  • R. Nuti
Clinical Investigations

Abstract

Bisphosphonates have been widely used in the treatment of osteoporosis in women, whereas until now there have been few data on their use in men. The aim of this study was to evaluate the effect of a 3-year alendronate treatment on bone mineral density (BMD) and quantitative ultrasound (QUS) in men with primary osteoporosis. We studied 77 osteoporotic men (aged 57.1 ± 10.8 yrs) who completed a 3-year treatment with alendronate (10 mg/day) plus calcium (1000 mg/day) (n = 39), or calcium alone (n = 38). At baseline and at a 12-month interval, we measured BMD at the lumbar spine and femur (femoral neck and total hip) by DXA (Hologic) and speed of sound (SOS), broadband ultrasound attenuation (BUA) and Stiffness (S) at the os calcis by Achilles plus (Lunar). Alendronate treatment had significantly increased lumbar spine BMD by 4.2% at year 1, by 6.3% at year 2, and 8.8% at year 3. BMD at the femoral neck and total hip had increased by 2.1% and 1.6% at year 1, by 3.2% and 2.9% at year 2, and by 4.2% and 3.9% at year 3, respectively. BUA and Stiffness showed a significant increase in the alendronate-treated group at year 2 (3.2% and 4.9%, respectively) and at year 3 (3.8% and 6%, respectively). BMD at the lumbar spine showed the best longitudinal sensitivity whereas longitudinal sensitivity of both QUS at the heel and femur BMD were similar. In conclusion, this study confirms that alendronate represents an important therapeutic advance in the management of male osteoporosis. BMD at the lumbar spine appears to be the best method for monitoring the effect of alendronate on bone mass in osteoporotic men.

Keywords

Male osteoporosis Alendronate Bone mineral density Quantitative ultrasound 

References

  1. 1.
    Melton III, LJ 2001The prevalence of osteoporosis: gender and racial comparison.Calcif Tissue Int69179181CrossRefPubMedGoogle Scholar
  2. 2.
    Seeman, E 1999Osteoporosis in men.Osteoporos Int (suppl)2S97S110Google Scholar
  3. 3.
    Cooper, C, Campion, G, Melton III, LJ 1992Hip fractures in the elderly: a world-wide projection.Osteoporos Int2285289PubMedGoogle Scholar
  4. 4.
    Orwoll, ES 1998Osteoporosis in men.Osteoporos Int27349367Google Scholar
  5. 5.
    O’Neill, TW, Felsenberg, D, Varlow, J, Cooper, C, Kanis, JA, Silman, AJ 1996The prevalence of vertebral deformity in European men and women: The European Vertebral Osteoporosis Study.J Bone Miner Res1110101018PubMedGoogle Scholar
  6. 6.
    Center, JR, Nguyen, TV, Schneider, D, Sambrook, PN, Eisman, JA 1999Mortality after all major types of osteoporotic fracture in men and women: an observational study.Lancet353878882PubMedGoogle Scholar
  7. 7.
    Katznelson, L, Finkelstein, JS, Schoenfeld, DA, Rosenthal, DI, Anderson, EJ, Klibanski, A 1996Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.J Clin Endocrinol Metab124358Google Scholar
  8. 8.
    Snyder, PJ, Peachey, H, Berlin, JA, Hannoush, P, Hadda, G, Dlewati, A, Santanna, J, Loh, I, Lenrow, DA, Olmes, JH, Kapoor, SC, Atkinson, LE, Strom, BL 1999Effect of testosterone replacement in hypogonadal men.J Clin Endocrinol Metab8419661972PubMedGoogle Scholar
  9. 9.
    Orwoll, E, Ettinger, M, Weiss, S, Miller, P, Kendler, D, Graham, J, Adami, S, Weber, K, Lorene, R, Pietschmann, P, Vandormacl, K, Lombardi, A 2000Alendronate for the treatment of osteoporosis in men.N Engl J Med343604610PubMedGoogle Scholar
  10. 10.
    Ho, YV, Frauman, AG, Thomson, W, Seeman, E 2000Effects of alendronate on bone density in men with primary and secondary osteoporosis.Osteoporos Int1198101PubMedGoogle Scholar
  11. 11.
    Ringe, JD, Faber, H, Dorst, A 2001Alendronate treatment of established primary osteoporosis in men: results of a two-year prospective study.J Clin Endocrinol Metab8652525255PubMedGoogle Scholar
  12. 12.
    Weber, T, Drezner, M 2001Effect of alendronate on bone mineral density in male idiopathic osteoporosis.Metabolism50912915CrossRefPubMedGoogle Scholar
  13. 13.
    Liberman, UA, Weiss, SR, Broll, J, Minnie, HW, Quan, H, Bell, NH, Rodriguez-Portales, J, Downs Jr, RW, Dequecker, J, Favus, M 1995Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis.N Engl J Med33314371443PubMedGoogle Scholar
  14. 14.
    Black, DM, Cummings, SR, Karpf, DB, Cauley, JA, Thompson, DE, Nevitt, MC, Bauer, DC, Genant, HK, Haskell, WL, Marcus, R, Ott, SM, Torner, JC, Quandt, SA, Reiss, TF, Ensrud, KE 1996Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures.Lancet34815351541for the Fracture Intervention Trial Research GroupPubMedGoogle Scholar
  15. 15.
    Cortet, B, Dubois, P, Boutry, N, Palos, G, Cotton, A, Marchandise, X 2002Computed tomography image analysis of the calcaneous in male osteoporosis.Osteoporos Int133341CrossRefGoogle Scholar
  16. 16.
    Legrand, E, Chappard, D, Pascaretti, C, Duquenne, M, Rondeau, C, Simon, Y, Rohmer, V, Basle, M.F., Audran, M 1999Bone mineral density and vertebral fractures in men.Osteoporos Int10265270CrossRefPubMedGoogle Scholar
  17. 17.
    Gluer, CC 1997Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status.J Bone Miner Res1212801288for the International Quantitative Ultrasound Consensus GroupPubMedGoogle Scholar
  18. 18.
    Gluer, CC, Wu, CY, Jergas, M, Goldstein, SA, Genant, HK 1994Three quantitative ultrasound parameters reflect bone structure.Calcif Tissue Int554652PubMedGoogle Scholar
  19. 19.
    Njeh, CF, Fuerst, T, Diessel, E, Genant, HK 2001Is quantitative ultrasound dependent on bone structure? A reflection.Osteoporos Int12115CrossRefPubMedGoogle Scholar
  20. 20.
    Hans, D, Dargent-Molina, P, Schott, AM, Sebert, JL, Cormier, C, Kotzki, PO, Delmas, PD, Pouilles, JM, Breart, G, Meunier, PG 1996Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study.Lancet348511514for the EPIDOS prospective study groupPubMedGoogle Scholar
  21. 21.
    Bauer, DC, Gluer, CC, Cauley, JA, Vogt, TM, Ensrud, KE, Genant, HK, Blake, DM 1997Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women.Arch Intern Med157629634for the study of osteoporotic fractures research groupPubMedGoogle Scholar
  22. 22.
    Sahota, O, San, P, Cawte, SA, Pearson, D, Hosking, DJ 2000A comparison of the longitudinal changes in quantitative ultrasound with dual-energy X-ray absorptiometry: the four-year effects of hormone replacement therapy.Osteoporos Int115258CrossRefPubMedGoogle Scholar
  23. 23.
    Gonnelli, S, Cepollaro, C, Montagnani, A, Martini, S, Gennari, L, Mangeri, M, Gennari, C 2002Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study.Osteoporos Int13415421CrossRefGoogle Scholar
  24. 24.
    Krieg, MA, Jacquet, AF, Bremgartner, M, Cuttelod, S, Thiebaud, D, Burckardt, P 1999Effect of supplementation with vitamin D3 and calcium on quantitative ultrasound of bone in elderly institutionalized women: a longitudinal study.Osteoporos Int9483488CrossRefPubMedGoogle Scholar
  25. 25.
    Pluskiewicz, W, Drozdzowska, B 1999Ultrasound measurements at the calcaneus in men: differences between healthy and fractured persons and the influence of age and anthropometric features on ultrasound parameters.Osteoporos Int104751CrossRefPubMedGoogle Scholar
  26. 26.
    Adler, RA, Funkhouser, HL, Holt, CM 2001Utility of heel ultrasound bone density in men.J Clin Densitom3225230Google Scholar
  27. 27.
    Montagnani, A, Gonnelli, S, Cepollaro, C, Mangeri, M, Monaco, R, Gennari, L, Gennari, C 2001Usefulness of bone quantitative ultrasound in management of osteoporosis in men.J Clin Densitom3231237Google Scholar
  28. 28.
    Mulleman, D, Legroux-Gerot, I, Duquesnoy, B, Marchandies, X, Delcambre, B, Cortet, B 2002Quantitative ultrasound in bone male osteoporosis.Osteoporos Int13388393CrossRefGoogle Scholar
  29. 29.
    Gluer, CC 1999Monitoring skeletal changes by radiological techniques.J Bone Miner Res1419521962PubMedGoogle Scholar
  30. 30.
    Tucci, JR, Tonino, RP, Emkey, RD, Peverly, CA, Kher, U, Santora II, AC 1996Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis.Am J Med101488501for the U.S. Alendronate Phase III Osteoporosis Treatment Study GroupCrossRefPubMedGoogle Scholar
  31. 31.
    Parfitt, AM 1980Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis.Miner Electrolyte Metab4273287Google Scholar
  32. 32.
    Hanson, J 1997Standardization of femur BMD (letter).J Bone Miner Res1213161317PubMedGoogle Scholar
  33. 33.
    Patel, R, Blake, GM, Rymer, J, Fogelman, I 2000Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women.Osteoporos Int116875CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • S. Gonnelli
    • 1
  • C. Cepollaro
    • 1
  • A. Montagnani
    • 1
  • D. Bruni
    • 1
  • C. Caffarelli
    • 1
  • M. Breschi
    • 1
  • L. Gennari
    • 1
  • C. Gennari
    • 1
  • R. Nuti
    • 1
  1. 1.Department of Internal Medicine, Endocrine-Metabolic Science and BiochemistryUniversity of SienaItaly

Personalised recommendations